TW200609001A - Particulate-stabilized injectable pharmaceutical compositions of posaconasole - Google Patents
Particulate-stabilized injectable pharmaceutical compositions of posaconasoleInfo
- Publication number
- TW200609001A TW200609001A TW094117524A TW94117524A TW200609001A TW 200609001 A TW200609001 A TW 200609001A TW 094117524 A TW094117524 A TW 094117524A TW 94117524 A TW94117524 A TW 94117524A TW 200609001 A TW200609001 A TW 200609001A
- Authority
- TW
- Taiwan
- Prior art keywords
- posaconasole
- particulate
- pharmaceutical compositions
- injectable pharmaceutical
- stabilized injectable
- Prior art date
Links
- 239000008194 pharmaceutical composition Substances 0.000 title 1
- 238000009472 formulation Methods 0.000 abstract 2
- 239000000203 mixture Substances 0.000 abstract 2
- 239000008186 active pharmaceutical agent Substances 0.000 abstract 1
- 208000015181 infectious disease Diseases 0.000 abstract 1
- 229940102213 injectable suspension Drugs 0.000 abstract 1
- RAGOYPUPXAKGKH-XAKZXMRKSA-N posaconazole Chemical compound O=C1N([C@H]([C@H](C)O)CC)N=CN1C1=CC=C(N2CCN(CC2)C=2C=CC(OC[C@H]3C[C@@](CN4N=CN=C4)(OC3)C=3C(=CC(F)=CC=3)F)=CC=2)C=C1 RAGOYPUPXAKGKH-XAKZXMRKSA-N 0.000 abstract 1
- 229960001589 posaconazole Drugs 0.000 abstract 1
- 230000001954 sterilising effect Effects 0.000 abstract 1
- 238000004659 sterilization and disinfection Methods 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/24—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Inorganic Chemistry (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Tropical Medicine & Parasitology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
The present invention provides formulations useful for treating infections, in particular, formulations that include the active pharmaceutical ingredient posaconazole in an injectable suspension that is stable when subjected to terminal steam sterilization.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US57512604P | 2004-05-28 | 2004-05-28 |
Publications (2)
Publication Number | Publication Date |
---|---|
TW200609001A true TW200609001A (en) | 2006-03-16 |
TWI290051B TWI290051B (en) | 2007-11-21 |
Family
ID=34971355
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
TW094117524A TWI290051B (en) | 2004-05-28 | 2005-05-27 | Particulate-stabilized injectable pharmaceutical compositions of Posaconazole |
Country Status (15)
Country | Link |
---|---|
EP (1) | EP1761247A1 (en) |
JP (1) | JP2008501034A (en) |
KR (1) | KR20070027564A (en) |
CN (1) | CN1988887A (en) |
AR (1) | AR049063A1 (en) |
AU (1) | AU2005249502A1 (en) |
CA (1) | CA2567803A1 (en) |
IL (1) | IL179627A0 (en) |
MX (1) | MXPA06013886A (en) |
NO (1) | NO20066005L (en) |
PE (1) | PE20060291A1 (en) |
RU (1) | RU2006146555A (en) |
TW (1) | TWI290051B (en) |
WO (1) | WO2005117831A1 (en) |
ZA (1) | ZA200609890B (en) |
Families Citing this family (22)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20060009469A1 (en) * | 2004-05-28 | 2006-01-12 | Leonore Witchey-Lakshmanan | Particulate-stabilized injectable pharmacutical compositions of posaconazole |
SI2018164T1 (en) | 2006-05-12 | 2017-07-31 | Christian Noe | Use of combination preparations comprising antifungal agents |
EP2130540A1 (en) * | 2008-06-02 | 2009-12-09 | Sandoz AG | Pharmaceutical compositions containing a crystalline form of posaconazole |
EP2141159A1 (en) | 2008-07-03 | 2010-01-06 | Sandoz AG | A Crystalline form of posaconazole |
EP2451805A1 (en) | 2009-07-09 | 2012-05-16 | Sandoz AG | A crystalline form of posaconazole |
AU2011254654B2 (en) | 2010-05-19 | 2016-01-07 | Sandoz Ag | Process for the preparation of chiral triazolones |
EP2571847B1 (en) | 2010-05-19 | 2016-09-21 | Sandoz AG | Process for the preparation of chiral hydrazides |
WO2011144657A1 (en) | 2010-05-19 | 2011-11-24 | Sandoz Ag | Purification of posaconazole and posaconazole intermediates |
CA2798007C (en) | 2010-05-19 | 2018-10-23 | Sandoz Ag | Preparation of posaconazole intermediates |
JP6008849B2 (en) | 2010-06-29 | 2016-10-19 | メルク・シャープ・エンド・ドーム・コーポレイション | Solution formulation for intravenous injection of posaconazole stabilized by substituted β-cyclodextrin |
WO2012172015A1 (en) | 2011-06-16 | 2012-12-20 | Sandoz Ag | Process for the preparation of a chiral compound |
CN103284959B (en) * | 2012-02-22 | 2015-06-03 | 重庆圣华曦药业股份有限公司 | Posaconazole freeze-dried powder injection and preparation method thereof |
CN102755628B (en) * | 2012-07-16 | 2013-10-23 | 中国科学院微生物研究所 | Antifungal pharmaceutical composition |
CN102805731B (en) * | 2012-08-22 | 2014-04-30 | 北京莱瑞森医药科技有限公司 | Posaconazole dry suspension and preparation method thereof |
CN105030668B (en) * | 2015-06-26 | 2018-03-27 | 济川药业集团有限公司 | Oral posaconazole supensoid agent and preparation method thereof |
CN106333925B (en) * | 2015-07-10 | 2019-06-18 | 上海美悦生物科技发展有限公司 | A kind of posaconazole liquid suspension and preparation method thereof |
CN105997872B (en) * | 2016-07-08 | 2019-02-19 | 河南省立眼科医院 | A kind of antimycotic solution of ophthalmically acceptable nano-micelle containing posaconazole |
MX2019011603A (en) * | 2017-03-26 | 2021-08-16 | Robyn Vivi Stafford | Method of treatment of skin conditions of eye lids. |
KR20200059188A (en) * | 2017-04-12 | 2020-05-28 | 비카쉬 제이. 바그완딘 | Composition, packaged medicament, and method using posaconazole for sensitization of resistant tumors |
CN110507609B (en) * | 2018-05-21 | 2021-09-17 | 上海医药工业研究院 | Preparation method of posaconazole oral suspension |
CN111514146A (en) * | 2020-04-28 | 2020-08-11 | 山西振东泰盛制药有限公司 | Pharmaceutical composition containing posaconazole |
CN113933131B (en) * | 2021-09-24 | 2024-01-26 | 合肥天一生物技术研究所有限责任公司 | Vaginal microorganism fluorescent staining solution |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5091188A (en) * | 1990-04-26 | 1992-02-25 | Haynes Duncan H | Phospholipid-coated microcrystals: injectable formulations of water-insoluble drugs |
MXPA03009021A (en) * | 2001-04-03 | 2004-02-12 | Schering Corp | Antifungal composition with enhanced bioavailability. |
-
2005
- 2005-05-27 AU AU2005249502A patent/AU2005249502A1/en not_active Abandoned
- 2005-05-27 RU RU2006146555/15A patent/RU2006146555A/en not_active Application Discontinuation
- 2005-05-27 EP EP05755118A patent/EP1761247A1/en not_active Withdrawn
- 2005-05-27 CN CNA2005800248542A patent/CN1988887A/en active Pending
- 2005-05-27 KR KR1020067024996A patent/KR20070027564A/en not_active Application Discontinuation
- 2005-05-27 MX MXPA06013886A patent/MXPA06013886A/en unknown
- 2005-05-27 JP JP2007515456A patent/JP2008501034A/en not_active Withdrawn
- 2005-05-27 TW TW094117524A patent/TWI290051B/en not_active IP Right Cessation
- 2005-05-27 PE PE2005000599A patent/PE20060291A1/en not_active Application Discontinuation
- 2005-05-27 AR ARP050102203A patent/AR049063A1/en not_active Application Discontinuation
- 2005-05-27 WO PCT/US2005/018945 patent/WO2005117831A1/en active Application Filing
- 2005-05-27 CA CA002567803A patent/CA2567803A1/en not_active Abandoned
-
2006
- 2006-11-27 ZA ZA200609890A patent/ZA200609890B/en unknown
- 2006-11-27 IL IL179627A patent/IL179627A0/en unknown
- 2006-12-22 NO NO20066005A patent/NO20066005L/en not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
KR20070027564A (en) | 2007-03-09 |
NO20066005L (en) | 2007-02-27 |
JP2008501034A (en) | 2008-01-17 |
EP1761247A1 (en) | 2007-03-14 |
PE20060291A1 (en) | 2006-04-14 |
AR049063A1 (en) | 2006-06-21 |
TWI290051B (en) | 2007-11-21 |
RU2006146555A (en) | 2008-07-20 |
MXPA06013886A (en) | 2007-01-26 |
ZA200609890B (en) | 2008-09-25 |
CN1988887A (en) | 2007-06-27 |
CA2567803A1 (en) | 2005-12-15 |
WO2005117831A1 (en) | 2005-12-15 |
IL179627A0 (en) | 2007-05-15 |
AU2005249502A1 (en) | 2005-12-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
TW200609001A (en) | Particulate-stabilized injectable pharmaceutical compositions of posaconasole | |
TW200633716A (en) | Compositions and methods for stabilizing active pharmaceutical ingredients | |
MY143795A (en) | Tetrahydropyridoindole derivatives | |
MX2009013810A (en) | Use of homo- and copolymers for stabilizing active ingredient formulations. | |
DE602005021770D1 (en) | INDOLE-1-YL-ACETIC DERIVATIVES | |
MX2022015272A (en) | Inhibitors of kras g12c protein and uses thereof. | |
NO20080338L (en) | Compounds for the treatment of multidrug-resistant bacterial infections | |
TW200640459A (en) | Particulate-stabilized injectable pharmaceutical compositions of posaconazole | |
NO20082269L (en) | NEW PIPERAZINES AS ANTIMAL ARIA AGENTS | |
IL184898A0 (en) | Pyrrolopyrimidine derivatives and pharmaceutical compositions containing the same | |
EA200802135A1 (en) | PHARMACEUTICAL COMPOSITIONS OF ANTAGONISTIC ANTIBODY TO CD40 | |
EA200802203A1 (en) | DIQUETOPYPERSON AND PIPERIDINE DERIVATIVES AS ANTIVIRAL AGENTS | |
BRPI0514736A (en) | sigma receptor inhibitors | |
EA200800798A1 (en) | PHARMACEUTICAL COMPOSITIONS INTENDED FOR THE TREATMENT OF DISTURBANCES OF THE INTERNAL EAR | |
MX2009003911A (en) | Enhanced immediate release formulations of topiramate. | |
WO2010111640A3 (en) | Anti-influenza formulations and methods | |
MX2009007784A (en) | Compositions of stable tiacumicins. | |
TW200621773A (en) | Bicyclononene derivatives | |
HK1120794A1 (en) | Substituted heterocycles, their use as medicament, and pharmaceutical preparations comprising them | |
EA200801614A1 (en) | PHARMACEUTICAL COMPOSITION CONTAINING MONTELUKAST | |
TW200628468A (en) | Bicyclononene derivatives | |
EP4272832A3 (en) | Antimicrobial compounds, compositions, and uses thereof | |
WO2008013823A3 (en) | Co-crystals of (2r-trans)-6-chloro-5-[[4-[(4-fluorophenyl)methyl]-2,5-dimethyl-1-piperazinyl]carbonyl]-n,n,1-trimethyl-alpha-oxo-1h-indole-3-acetamide | |
TW200621774A (en) | Bicyclononene derivatives | |
MY160904A (en) | Piperazines as antimalarial agents |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MM4A | Annulment or lapse of patent due to non-payment of fees |